compounded semaglutide lawsuit update FDA faces new from compounders over wight loss drugs semaglutide lawsuit compounding Filed Against

Semaglutide is a medication that works by copying the effects of a hormone called GLP-1, which makes patients feel full after eating

NAD IV therapy is a specialized intravenous treatment that delivers high doses of NAD directly into the bloodstream

NAIONs pathophysiology remains incompletely understood but involves vascular dysregulation, possibly exacerbated by drug-induced sympathetic nervous system changes and optic nerve head vulnerabilities such as a smaller Bruchs membrane opening

These researchers incorporated elimination of major glycan antigens, insertion of multiple human immunoregulatory and anticoagulant genes, and complete inactivation of porcine endogenous retroviruses (PERVs), reflecting a design philosophy aimed at maximizing long-term immunologic compatibility and infectious safety (Kawai et al, N Engl J Med 2025)